Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma. Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Benha University, Egypt.Clin Biochem. 2008 Jun 20; : 18616935 (P,S,G,E,B,D) Glypican-3 as a Tumor Marker for Hepatocellular Carcinoma Telomerase Reverse Transcriptase Gene Expression as a Tumor Marker for Hepatocellular Carcinoma Fas and Fas-Ligand as Markers for Response to Interferon plus Ribavirin Therapy in Egyptian Patients with Chronic Hepatitis C Lymphocyte Subgroups and Tumor Necrosis Factor-α and Interleukin-6 in Ascitic Fluid and Serum of Patients with Spontaneous Bacterial Peritonitis at Benha University Hospital The Potential Beneficial Effects of Melatonin on Hepatic Fibrosis in Rats Prevalence of Hydatidosis in Qualubia Governorate Evaluation of MELD Scores and Intrarenal Arterial Resistive Index in Cirrhotic Patients with Hepatorenal Syndrome Assessment of Eight Non-Invasive Markers of Liver Fibrosis in Egyptian Patients with Chronic Hepatitis C RECK gene polymorphism in patients with hepatocellular carcinoma Osteopontin as A Tumor Marker for Hepatocellular Carcinoma Diagnostic and Prognostic Values of Monocyte Chemotactic Protein-1 in Ascitic Fluid of Patients with Spontaneous Bacterial Peritonitis Clinical Relevance of the cagA,vacA and babA2 Virulence Factors ofHelicobacter pylori in Egyptian Patients with Gastroduodenal Diseases. Expression of Vascular Endothelial Growth Factor in the Gastric Mucosa of Patients with Portal Hypertensive Gastropathy Predictive and Prognostic Value of Von Willebrand Factor in Patients with Cirrhosis and Esophageal Varices Serum Sodium Concentration Profile in Cirrhotic Patients and its Effect on the Prognostic Value of the MELD Score Serum Interleukin-6 Concentration Associated with Response to Therapy for Chronic Hepatitis C Patients